← Leaderboards
Nancy J Rusch
Medical College Of Wisconsin
$9,133,831
Attributed
$9,368,728
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,368,728 · 6
By mechanism
R01$8,226,219 · 4
TL1$789,011 · 1
R21$353,498 · 1
Top collaborators
- Curtis L Lowery2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Girija G. Konduri$5,106,387
- Leif D Nelin$2,929,303
- Richard J Roman$24,830,808
- Jack G Kleinman$1,320,656
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseAntihypertensive AgentsBaseDesignCalcium ChannelHypertensionBlood PressureVoltagePatch ClampIn VivoVoltage /Patch ClampVascular Smooth MuscleProteinsBlood VesselsSmooth Muscle MyocytesIn VitroSurfaceEssential HypertensionOverexpressionArteriesCalciumMouse ModelGenesLaboratory Rat
Grant awards (33)
J. NRSA Training$319,216
TL1 · FY2021 · TR · contact PI
J. NRSA Training$319,864
TL1 · FY2020 · TR · contact PI
J. NRSA Training$149,931
TL1 · FY2019 · TR · contact PI
Doxorubicin suppression of lymphatic function and therapeutic reversal$160,545
R21 · FY2016 · CA · contact PI
Doxorubicin suppression of lymphatic function and therapeutic reversal$192,953
R21 · FY2015 · CA · contact PI
Long-term Antihypertensive Therapy by Delivery of the BK Channel Gene to VSMCs$358,875
R01 · FY2012 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$356,190
R01 · FY2012 · HL · contact PI
Long-term Antihypertensive Therapy by Delivery of the BK Channel Gene to VSMCs$362,500
R01 · FY2011 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$359,788
R01 · FY2011 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$390,702
R01 · FY2010 · HL · contact PI
Long-term Antihypertensive Therapy by Delivery of the BK Channel Gene to VSMCs$362,500
R01 · FY2010 · HL · contact PI
Long-term Antihypertensive Therapy by Delivery of the BK Channel Gene to VSMCs$362,500
R01 · FY2009 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$359,788
R01 · FY2009 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$16,907
R01 · FY2009 · HL · contact PI
Vascular Calcium Channel Expression in Hypertension$6,496
R01 · FY2009 · HL · contact PI
Calcium Channels in Neonatal Pulmonary Hypertension$391,361
R01 · FY2008 · HL · contact PI
Calcium Channels in Neonatal Pulmonary Hypertension$391,582
R01 · FY2007 · HL · contact PI
Calcium Channels in Neonatal Pulmonary Hypertension$395,506
R01 · FY2006 · HL · contact PI
Renovascular Calcium Channels in Hypertension$277,326
R01 · FY2006 · HL · contact PI
Calcium Channels in Neonatal Pulmonary Hypertension$404,383
R01 · FY2005 · HL
Role of Cerebrovascular K+ Channels in Hypertension$308,700
R01 · FY2005 · HL
Renovascular Calcium Channels in Hypertension$284,000
R01 · FY2005 · HL
Role of Cerebrovascular K+ Channels in Hypertension$66,300
R01 · FY2005 · HL
Role of Cerebrovascular K+ Channels in Hypertension$375,000
R01 · FY2004 · HL
Renovascular Calcium Channels in Hypertension$155,823
R01 · FY2004 · HL
Renovascular Calcium Channels in Hypertension$144,177
R01 · FY2004 · HL
Role of Cerebrovascular K+ Channels in Hypertension$375,000
R01 · FY2003 · HL
Renovascular Calcium Channels in Hypertension$300,000
R01 · FY2003 · HL
Role of Cerebrovascular K+ Channels in Hypertension$361,200
R01 · FY2002 · HL
RENOVASCULAR CA2+ CHANNEL EXPRESSION IN HYPERTENSION$261,625
R01 · FY2002 · HL
RENOVASCULAR CA2+ CHANNEL EXPRESSION IN HYPERTENSION$261,625
R01 · FY2001 · HL
CEREBROVASCULAR POTASSIUM CHANNELS AND HYPERTENSION$274,740
R01 · FY2000 · HL
RENOVASCULAR CA2+ CHANNEL EXPRESSION IN HYPERTENSION$261,625
R01 · FY2000 · HL